Serum Institute gets DCGI nod for trials of Oxford vaccine
The University of Oxford’s vaccine candidate is seen as the front runner among the candidates undergoing trials
NEW DELHI : The Drug Controller General of India’s (DCGI’s) office has approved the Serum Institute of India’s application for phase II and III clinical trials of the University of Oxford’s covid-19 vaccine candidate Covishield, the Union health ministry said on Monday.
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more